Natixis Advisors LLC Trims Position in Cabot Corporation $CBT

Natixis Advisors LLC cut its holdings in shares of Cabot Corporation (NYSE:CBT) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 189,385 shares of the specialty chemicals company’s stock after selling 11,649 shares during the period. Natixis Advisors LLC owned 0.36% of Cabot worth $12,552,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in CBT. Farther Finance Advisors LLC grew its stake in Cabot by 9.6% in the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock worth $124,000 after purchasing an additional 164 shares during the period. Gabelli Funds LLC grew its stake in Cabot by 1.3% in the third quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after purchasing an additional 180 shares during the period. Rothschild Investment LLC grew its stake in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the period. Allworth Financial LP grew its stake in Cabot by 22.4% in the fourth quarter. Allworth Financial LP now owns 1,455 shares of the specialty chemicals company’s stock worth $96,000 after purchasing an additional 266 shares during the period. Finally, Hantz Financial Services Inc. grew its stake in Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 298 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Trading Down 2.6%

Shares of NYSE:CBT opened at $80.86 on Friday. The company has a market cap of $4.17 billion, a P/E ratio of 15.28, a PEG ratio of 10.67 and a beta of 0.82. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $89.46. The stock’s fifty day moving average price is $79.11 and its 200-day moving average price is $73.00.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. During the same period in the prior year, the company posted $1.90 earnings per share. The company’s quarterly revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Sell-side analysts expect that Cabot Corporation will post 6.32 earnings per share for the current year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be issued a $0.4725 dividend. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s dividend payout ratio is currently 35.73%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Mizuho upped their price target on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. upped their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. UBS Group upped their price target on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Finally, Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $80.25.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.